Adicet Bio Stock Price Prediction

ACET Stock  USD 2.20  0.04  1.85%   
At this time, The relative strength index (RSI) of Adicet Bio's share price is at 52. This suggests that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Adicet Bio, making its price go up or down.

Oversold Vs Overbought

52

 
Oversold
 
Overbought
Adicet Bio stock price prediction is an act of determining the future value of Adicet Bio shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Adicet Bio's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Adicet Bio and does not consider all of the tangible or intangible factors available from Adicet Bio's fundamental data. We analyze noise-free headlines and recent hype associated with Adicet Bio, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Adicet Bio's stock price prediction:
EPS Estimate Next Quarter
(0.58)
EPS Estimate Current Year
(1.86)
EPS Estimate Next Year
(1.88)
Wall Street Target Price
9
EPS Estimate Current Quarter
(0.69)
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Adicet Bio based on different types of headlines from major news networks to social media. The Adicet stock price prediction module provides an analysis of price elasticity to changes in media outlook on Adicet Bio over a specific investment horizon. Using Adicet Bio hype-based prediction, you can estimate the value of Adicet Bio from the perspective of Adicet Bio response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Adicet Bio using Adicet Bio's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Adicet using crowd psychology based on the activity and movement of Adicet Bio's stock price.

Adicet Bio Implied Volatility

    
  0.0  
Adicet Bio's implied volatility exposes the market's sentiment of Adicet Bio stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Adicet Bio's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Adicet Bio stock will not fluctuate a lot when Adicet Bio's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Adicet Bio. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Adicet Bio to buy its stock at a price that has no basis in reality. In that case, they are not buying Adicet because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Adicet Bio after-hype prediction price

    
  USD 2.18  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Adicet Bio Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Adicet Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
1.966.6911.42
Details
8 Analysts
Consensus
LowTargetHigh
18.5020.3322.57
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.51-0.39-0.27
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Adicet Bio. Your research has to be compared to or analyzed against Adicet Bio's peers to derive any actionable benefits. When done correctly, Adicet Bio's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Adicet Bio.

Adicet Bio After-Hype Price Prediction Density Analysis

As far as predicting the price of Adicet Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Adicet Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Adicet Bio, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Adicet Bio Estimiated After-Hype Price Volatility

In the context of predicting Adicet Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Adicet Bio's historical news coverage. Adicet Bio's after-hype downside and upside margins for the prediction period are 0.11 and 6.91, respectively. We have considered Adicet Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
2.20
2.18
After-hype Price
6.91
Upside
Adicet Bio is moderately volatile at this time. Analysis and calculation of next after-hype price of Adicet Bio is based on 3 months time horizon.

Adicet Bio Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Adicet Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Adicet Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Adicet Bio, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.24 
4.69
  0.02 
  0.04 
11 Events / Month
14 Events / Month
In about 11 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
2.20
2.18
0.91 
5,862  
Notes

Adicet Bio Hype Timeline

Adicet Bio is presently traded for 2.20. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of 0.04. Adicet is forecasted to decline in value after the next headline, with the price expected to drop to 2.18. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.91%, whereas the daily expected return is presently at -0.24%. The volatility of related hype on Adicet Bio is about 3193.91%, with the expected price after the next announcement by competition of 2.24. About 68.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.04. Some equities with similar Price to Book (P/B) outperform the market in the long run. Adicet Bio has Price/Earnings To Growth (PEG) ratio of 0.82. The entity recorded a loss per share of 3.31. The firm last dividend was issued on the 16th of September 2020. Adicet Bio had 1:7 split on the 16th of September 2020. Given the investment horizon of 90 days the next forecasted press release will be in about 11 days.
Check out Adicet Bio Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.

Adicet Bio Related Hype Analysis

Having access to credible news sources related to Adicet Bio's direct competition is more important than ever and may enhance your ability to predict Adicet Bio's future price movements. Getting to know how Adicet Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Adicet Bio may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
EWTXEdgewise Therapeutics 0.05 8 per month 4.04  0.11  7.57 (6.20) 45.27 
TALSTalaris Therapeutics(0.07)7 per month 8.16  0.05  3.48 (4.96) 59.33 
CGEMCullinan Oncology LLC(1.07)10 per month 2.71  0.16  7.82 (4.55) 23.70 
VORVor Biopharma(0.10)9 per month 0.00 (0.13) 7.24 (7.96) 18.80 
TNYATenaya Therapeutics 0.16 9 per month 5.55  0.1  14.80 (9.77) 40.85 
BCYCBicycle Therapeutics 0.97 7 per month 2.89  0.06  3.73 (3.54) 33.06 
IGMSIGM Biosciences 0.37 9 per month 0.00 (0.01) 11.97 (12.89) 35.92 
GLUEMonte Rosa Therapeutics(0.46)8 per month 7.51  0.01  10.84 (10.16) 38.28 
STOKStoke Therapeutics 2.97 7 per month 4.39  0.16  22.86 (8.17) 63.72 
AVTEAerovate Therapeutics 1.11 6 per month 4.66  0.08  11.11 (6.86) 28.53 
ACRVAcrivon Therapeutics Common 0.86 8 per month 4.65  0.14  17.65 (8.80) 73.36 
ANEBAnebulo Pharmaceuticals 0.14 5 per month 3.39  0.09  6.20 (5.51) 20.75 
AGIOAgios Pharm(0.31)10 per month 1.82  0.10  7.26 (3.52) 15.13 
FIXXHomology Medicines 0.07 5 per month 11.22  0.12  10.00 (3.26) 1,764 
NKTXNkartaInc(0.21)8 per month 7.51  0.01  12.36 (8.95) 50.11 
PLRXPliant TherapeuticsInc(0.37)10 per month 0.00 (0.1) 4.22 (6.56) 20.57 
ALECAlector(0.30)7 per month 0.00 (0.10) 5.96 (8.23) 16.43 
AADIAadi Bioscience(0.03)9 per month 4.07  0.03  6.74 (5.63) 40.61 
KROSKeros TherapeuticsInc(0.99)8 per month 3.11  0.06  5.20 (5.18) 12.93 

Adicet Bio Additional Predictive Modules

Most predictive techniques to examine Adicet price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Adicet using various technical indicators. When you analyze Adicet charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Adicet Bio Predictive Indicators

The successful prediction of Adicet Bio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Adicet Bio, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Adicet Bio based on analysis of Adicet Bio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Adicet Bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Adicet Bio's related companies.
 2023 2024 (projected)
Dividend Yield0.01930.0155
Price To Sales Ratio13.2313.33

Story Coverage note for Adicet Bio

The number of cover stories for Adicet Bio depends on current market conditions and Adicet Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Adicet Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Adicet Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Adicet Bio Short Properties

Adicet Bio's future price predictability will typically decrease when Adicet Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Adicet Bio often depends not only on the future outlook of the potential Adicet Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Adicet Bio's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding43 M
Cash And Short Term Investments159.7 M
When determining whether Adicet Bio is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Adicet Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Adicet Bio Stock. Highlighted below are key reports to facilitate an investment decision about Adicet Bio Stock:
Check out Adicet Bio Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.
Note that the Adicet Bio information on this page should be used as a complementary analysis to other Adicet Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Complementary Tools for Adicet Stock analysis

When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Is Adicet Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adicet Bio. If investors know Adicet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adicet Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.31)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.31)
Return On Equity
(0.62)
The market value of Adicet Bio is measured differently than its book value, which is the value of Adicet that is recorded on the company's balance sheet. Investors also form their own opinion of Adicet Bio's value that differs from its market value or its book value, called intrinsic value, which is Adicet Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adicet Bio's market value can be influenced by many factors that don't directly affect Adicet Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adicet Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adicet Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adicet Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.